Previous 10 | Next 10 |
Co-Diagnostics, Inc. to Present at MarketsandMarkets Conference on March 23-24 in London, England PR Newswire SALT LAKE CITY , March 22, 2022 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company"), a molecular diagnostics company with a u...
Co-Diagnostics, Inc. Makes Strategic Additions to Scientific Advisory Board PR Newswire SALT LAKE CITY , March 17, 2022 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company"), a molecular diagnostics company with a unique, patented ...
Shares of Co-Diagnostics (NASDAQ: CODX) are soaring 15.3% at 11:28 a.m. ET today, after the molecular diagnostics company announced it would buy back $30 million worth of its shares. While the company says it's under no obligation to actually start or even complete the share rep...
Gainers: Incannex Healthcare IXHL +209%. Revelation Biosciences (NASDAQ:REVB) +25%. Co-Diagnostics CODX +14%. GreenLight Biosciences (NASDAQ:GRNA) +14%. Clearside Biomedical (NASDAQ:CLSD) +12%. Losers: Better Therapeutics BTTX -33%. ANI Pharmaceuticals ...
Co-Diagnostics (CODX +4.4%) has received Board's approval to repurchase up to $30M of its common share under the new buyback program. "This share repurchase program is aligned with our commitment to return value to our shareholders and reflects confidence in our balance sheet and strong ...
Co-Diagnostics, Inc. Announces Authorization of $30 Million Share Repurchase Program PR Newswire SALT LAKE CITY , March 15, 2022 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company"), a molecular diagnostics company with a unique, ...
CO-DIAGNOSTICS, INC. ANNOUNCES FOURTH QUARTER AND FULL YEAR 2021 EARNINGS RELEASE DATE AND WEBCAST PR Newswire SALT LAKE CITY , March 14, 2022 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patente...
Co-Diagnostics, Inc. to Sponsor and Present at Molecular Med Tri-Con 2022 PR Newswire SALT LAKE CITY , Feb. 17, 2022 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company"), a molecular diagnostics company with a unique, patented platform for the...
Co-Diagnostics, Inc. to Host Booth at Life Sciences Day on the Hill on February 16 at the Utah State Capital PR Newswire SALT LAKE CITY , Feb. 10, 2022 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company"), a molecular diagnostics company with a...
Co-Diagnostics (NASDAQ:CODX) announced its joint venture in India, CoSara Diagnostics, received clearance from the regulatory authorities to manufacture and sell SARAQ Hepatitis B (HBV) Viral Load Kit there as an in vitro diagnostic ("IVD"). The real-time PCR test for HBV is based on Co-Diagn...
News, Short Squeeze, Breakout and More Instantly...
Co-Diagnostics, Inc. to Host Booth and Discuss Advancing POC/OTC Diagnostics at ADLM 2024 in Chicago PR Newswire SALT LAKE CITY , July 29, 2024 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company wi...
Co-Diagnostics, Inc. Announces Second Quarter 2024 Earnings Release Date and Webcast PR Newswire SALT LAKE CITY , July 25, 2024 /PRNewswire/ -- Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the developme...
Co-Diagnostics, Inc. Expands Vector Control Customer Base to 25 Customers across 15 U.S. States PR Newswire SALT LAKE CITY , July 2, 2024 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx™"), a molecular diagnostics company w...